Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 28, 2014

Vision as an Assessment for Disability and QoL in Multiple Sclerosis

Journal of Neuro-Ophthalmology


Additional Info

Journal of Neuro-Ophthalmology
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life
J Neuroophthalmol 2014 Nov 03;[EPub Ahead of Print], S Chahin, LJ Balcer, DM Miller, A Zhang, SL Galetta

Further Reading